Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

983.10INR
28 Aug 2014
Price Change (% chg)

Rs4.60 (+0.47%)
Prev Close
Rs978.50
Open
Rs970.15
Day's High
Rs1,019.00
Day's Low
Rs970.15
Volume
14,529
Avg. Vol
14,982
52-wk High
Rs1,286.00
52-wk Low
Rs725.20

ASTR.NS

Chart for ASTR.NS

About

AstraZeneca Pharma India Limited is an India-based pharmaceutical company. The Company operates in three segments: healthcare, clinical trial services and co-promotional services. The healthcare segment is engaged in the manufacture and sale of pharmaceutical products. The clinical trial services segment offers clinical trial... (more)
No analyst recommendations are available for ASTR.NS.

Overall

Beta: 0.79
Market Cap (Mil.): Rs24,577.50
Shares Outstanding (Mil.): 25.00
Dividend: --
Yield (%): --

Financials

  ASTR.NS Industry Sector
P/E (TTM): -- 32.30 33.23
EPS (TTM): -0.20 -- --
ROI: -0.37 17.96 17.21
ROE: -0.38 18.60 18.01
Search Stocks

Astrazeneca Pharma India falls; SEBI says exchanges to monitor delisting

MUMBAI - Shares in Astrazeneca Pharma India Ltd fell 3 percent after the SEBI on Tuesday said stock exchanges will closely monitor the company's delisting process and promptly report any aberrations.

25 Jun 2014

Astrazeneca Pharma India falls; SEBI says exchanges to monitor delisting

MUMBAI, June 25 - Shares in Astrazeneca Pharma India Ltd fell 3 percent after India's market regulator on Tuesday said stock exchanges will closely monitor the company's delisting process and promptly report any aberrations.

25 Jun 2014

Indian shares inch down; ITC slumps most in about 10 months

* BSE index falls 0.3 pct; NSE ends 0.24 pct lower * Sugar refiners gain as govt plans to raise import duty * Essar Oil, AstraZeneca surge on delisting plans By Abhishek Vishnoi MUMBAI, June 23 - Indian shares fell for a fourth straight session on Monday, marking their lowest close in 2-1/2 weeks as ITC Ltd slumped the most in ten months on tax worries, while concerns over high oil prices feeding inflation continued to weigh. Brent crude was up at around $115 a bar

23 Jun 2014

Essar Oil, AstraZeneca shares gain on delisting plans

Reuters Market Eye - Shares of Essar Oil Ltd and AstraZeneca Pharma India Ltd gain on plans of delisting the companies from Indian exchanges.

23 Jun 2014

MARKET EYE-India's Essar Oil, AstraZeneca shares gain on delisting plans

* Shares of India's Essar Oil Ltd and AstraZeneca Pharma India Ltd gain on plans of delisting the companies from Indian exchanges. * Essar Oil gains as much as 4.97 percent to its daily limit after the company's board approved a proposal to delist the company from the exchanges. * AstraZeneca Pharma India, the local unit of AstraZeneca Plc , surges as much as 9.95 percent after the company said its shareholders approved a proposal to delist the company from the bourses. (indulal.p@thomsonreu

23 Jun 2014

Indian unit of AstraZeneca up on Pfizer offer for parent

Reuters Market Eye - Shares of Astrazeneca Pharma India Ltd , the Indian unit of AstraZeneca Plc , rise 2.5 percent as the British drugmaker is approached by Pfizer Inc for a potential $100 billion takeover.

29 Apr 2014

MARKET EYE-Indian unit of AstraZeneca up on Pfizer offer for parent

* Shares of Astrazeneca Pharma India Ltd, the Indian unit of AstraZeneca Plc, rise 2.5 percent as the British drugmaker is approached by Pfizer Inc for a potential $100 billion takeover. * Astrazeneca Pharma India shares have gained 53 percent since January on speculation that its parent would be a takeover candidate. * Astrazeneca Plc holds a 75 percent stake in its Indian subsidiary, BSE data shows. (abhishek.vishnoi@thomsonreuters.com / abhishek.vishnoi.thomsonreuters.com@reuters.net)

29 Apr 2014

Astrazeneca's Indian unit surges on takeover media report

Reuters Market Eye - Shares in Astrazeneca Pharma India gain 3.8 percent after the Sunday Times newspaper reported Pfizer Inc has approached its parent AstraZeneca PLC to propose a 60 billion pound ($101 billion) takeover.

21 Apr 2014

MARKET EYE -Astrazeneca's Indian unit surges on takeover media report

* Shares in Astrazeneca Pharma India Ltd gain 3.8 percent after the Sunday Times newspaper reported Pfizer Inc has approached its parent AstraZeneca PLC to propose a 60 billion pound ($101 billion) takeover. * The British paper cited senior investment bankers and industry sources saying that informal conversations about a deal had taken place between the two, but that no talks were currently under way after AstraZeneca resisted the approach. * Pfizer and AstraZeneca both declined to comment

21 Apr 2014

AstraZeneca India unit sets floor price for stock delisting

REUTERS - AstraZeneca Pharma India Ltd , a unit of British drugmaker AstraZeneca Plc , said on Friday the floor price for its delisting from the Indian stock exchanges had been set at 854.1 rupees a share.

11 Apr 2014

Earnings vs. Estimates

No consensus analysis data available.
Search Stocks